Pricing
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Hugh Y. Rienhoff, Jr.
15 people · 0 jobs
9 people · 0 jobs
5 people · 0 jobs
4 people · 0 jobs
3 people · 0 jobs
HQ
1 person · 0 jobs
Dyno Therapeutics
4 followers
Eikon Therapeutics
3 followers
Sutro Biopharma
Active Motif
MedSchoolCoach
2 followers
Janux Therapeutics
1 follower
TwinStrand Biosciences
ParentSquare
Cellares
5 followers
Gilead Sciences
178 followers
Regeneron
145 followers
View more